Professor of Molecular Oncology (Clinical)
University of Liverpool
Professor Field is a Visiting Professor at University College London and holds the post of Director of Research at the Roy Castle Lung Cancer Research Programme. Professor Field is the Chief Investigator for the UK Lung Cancer Screening Trial (UKLS). He formed the IASLC Strategic Screening Advisory Group and is the past Chair of the IASLC Screening Prevention & Early Detection Committee steering committee. He is a member of the International Lung Cancer Consortium (ILCCO). Professor Field is the Principal Investigator of the Liverpool Lung Project (LLP), a molecular-epidemiological study for the early detection of lung cancer.
The (LLP) is a molecular- epidemiological study into the early detection of lung cancer, approximately 14,000 recruited participants over the last 21 years; developed the LLP risk prediction model and provided bio-specimens for the successful ILCCO GWAS programmes. The UKLS trial was the first RCT lung cancer screening trial to utilise a risk prediction model (LLP) to select patients with a high-risk of developing lung cancer. The LLP risk model is now incorporated into the large NHS Eng. Targeted Lung Health Check programme. The Liverpool research group has participated in a number of European funded projects (including the FP5, FP7, & Horizon2020) and currently the NIH U19 INTEGRAL project.
Professor Field is the author of over 340 international peer-reviewed papers and has delivered more than 360 presentations at medical and scientific conferences around the world. He was presented with the IASLC Joseph Cullen Award at the 2011 World Conference on Lung Cancer, in recognition of lifetime scientific achievements in lung cancer prevention research.